MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Alpha Cognition Inc. - Common Stock (NQ:ACOG)

8.890 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 8.890
Bid (Size) 7.500 (300)
Ask (Size) 9.000 (1,400)
Prev. Close 8.890
Today's Range 8.890 - 8.890
52wk Range 4.500 - 10.10
Shares Outstanding 146,925,149
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Alpha Cognition to Report Second Quarter 2026 Financial Results and Provide Business Update
From Alpha Cognition Inc.
Via Business Wire
News headline image
Alpha Cognition Receives European Patent Covering ZUNVEYL® for the Treatment of Mild-to-Moderate Alzheimer’s Disease
From Alpha Cognition Inc.
Via Business Wire

Performance

YTD
+36.8%
+36.8%
1 Month
+6.1%
+6.1%
3 Month
+49.4%
+49.4%
6 Month
+80.7%
+80.7%
1 Year
-11.0%
-11.0%

More News

Read More
News headline image
Alpha Cognition to Participate in Panel Discussion at the B. Riley Securities Mind, Muscle & Vision Summit
From Alpha Cognition Inc.
Via Business Wire
News headline image
Alpha Cognition Announces Election of Dr. Robert Wills as Chairman of the Board
From Alpha Cognition Inc.
Via Business Wire
Alpha Cognition (NASDAQ:ACOG) Q1 Revenue Meets Estimates as Commercial Momentum Builds ↗
Via Chartmill
Alpha Cognition Inc. (NASDAQ:ACOG) Reports Q4 Revenue Miss Amid Strong Alzheimer's Drug Launch ↗
Via Chartmill
News headline image
Alpha Cognition Announces First Patient Enrolled in RESOLVE Phase 4 Study Evaluating ZUNVEYL® in Patients with Mild to Moderate Alzheimer’s Disease
From Alpha Cognition, Inc.
Via Business Wire
News headline image
Alpha Cognition Reports Positive Top-Line Results from BEACON Real-World Study of ZUNVEYL® in Alzheimer’s Disease
From Alpha Cognition Inc.
Via Business Wire
News headline image
Alpha Cognition Q1 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
Alpha Cognition (ACOG) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Alpha Cognition Inc. Reports First Quarter 2026 Financial Results and Provides Operational Update
From Alpha Cognition Inc.
Via Business Wire
News headline image
Alpha Cognition (Nasdaq: ACOG) to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, May 14, 2026
From Alpha Cognition Inc.
Via Business Wire
News headline image
Alpha Cognition Inc. to Participate in Three Upcoming Investor Conferences
From Alpha Cognition, Inc.
Via Business Wire
News headline image
Alpha Cognition Strengthens Its Board of Directors with Appointment of Bethany Sensenig
From Alpha Cognition Inc.
Via Business Wire
News headline image
Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Alpha Cognition Inc.
Via Business Wire
News headline image
Alpha Cognition Receives Issued U.S. Patent for ALPHA-1062 for Treatment of Traumatic Brain Injury
From Alpha Cognition Inc.
Via Business Wire
News headline image
Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) Q425
Via Newsfile
News headline image
Alpha Cognition (ACOG) Q4 2025 Earnings Transcript ↗
Via The Motley Fool
News headline image
Alpha Cognition Inc. Reports Fiscal 2025 Financial Results and Provides Operational Update
From Alpha Cognition Inc.
Via Business Wire
News headline image
Water Giant With $7 Billion in Revenue Draws $7.5 Million Investment, and Shares Are Surging This Year ↗
Via The Motley Fool
News headline image
Payments Stock Down 30% Draws $6 Million Bet as Company Posts $4 Billion in Revenue ↗
Via The Motley Fool
News headline image
Alpha Cognition (Nasdaq: ACOG) to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on Thursday, March 26, 2026
From Alpha Cognition Inc.
Via Business Wire
News headline image
Alpha Cognition to Present New Clinical on ZUNVEYL® (Benzgalantamine) at Multiple Upcoming Alzheimer’s Association International Conferences
From Alpha Cognition Inc.
Via Business Wire
News headline image
Solas Capital Loads Up On Kyndryl With 407,000 Shares Bought ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Alpha Cognition Announces First Patient Enrolled in BEACON Real-World Effectiveness Study
From Alpha Cognition Inc.
Via Business Wire

Frequently Asked Questions

Is Alpha Cognition Inc. - Common Stock publicly traded?
Yes, Alpha Cognition Inc. - Common Stock is publicly traded.
What exchange does Alpha Cognition Inc. - Common Stock trade on?
Alpha Cognition Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Alpha Cognition Inc. - Common Stock?
The ticker symbol for Alpha Cognition Inc. - Common Stock is ACOG on the Nasdaq Stock Market
What is the current price of Alpha Cognition Inc. - Common Stock?
The current price of Alpha Cognition Inc. - Common Stock is 8.890
When was Alpha Cognition Inc. - Common Stock last traded?
The last trade of Alpha Cognition Inc. - Common Stock was at 08/10/26 04:00 PM ET
What is the market capitalization of Alpha Cognition Inc. - Common Stock?
The market capitalization of Alpha Cognition Inc. - Common Stock is 1.31B
How many shares of Alpha Cognition Inc. - Common Stock are outstanding?
Alpha Cognition Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story